首页> 美国卫生研究院文献>International Journal of Womens Dermatology >Art of prevention: Our approach to the measles-mumps-rubella vaccine in adult patients vaccinated against measles before 1968 on biologic therapy for the treatment of psoriasis
【2h】

Art of prevention: Our approach to the measles-mumps-rubella vaccine in adult patients vaccinated against measles before 1968 on biologic therapy for the treatment of psoriasis

机译:预防手段:1968年之前针对麻疹进行生物治疗的成年麻疹疫苗成人患者的麻疹-腮腺炎-风疹疫苗治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In response to the evolving measles epidemic in the United States, the Centers for Disease Control and Prevention recommended that some adults be revaccinated against measles because they may have inadequate immunity against the virus. Patients receiving biologic medications for psoriasis face a clinical dilemma because they may be at an increased risk of developing severe measles; however, vaccination with the measles-mumps-rubella (MMR) vaccine is not recommended for those on biologic therapy according to the American Academy of Dermatology-National Psoriasis Foundation guidelines.
机译:为了应对美国不断发展的麻疹流行病,疾病控制与预防中心建议对一些成年人进行麻疹疫苗接种,因为他们对这种病毒的免疫力可能不足。接受生物药物治疗牛皮癣的患者面临临床困境,因为他们患上严重麻疹的风险可能会增加;但是,根据美国皮肤病学会-国家银屑病基金会指南,不建议将麻疹-腮腺炎-风疹(MMR)疫苗用于生物治疗人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号